Eastman Chemical Company has revealed a dramatic decline in its fourth-quarter 2025 earnings, reporting a profit of 92 cents per share—down 67% from the previous year. This downturn is exacerbated by a 12.1% drop in revenues, totaling $1.97 billion, and persistent demand weakness in consumer markets. Despite ongoing cost-cutting measures that have yielded around $100 million in savings, analysts suggest the company is likely to continue underperforming compared to the overall market.